Day: February 18, 2025

HOUSTON , Feb. 18, 2025 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its fourth quarter 2024 financial results. The earnings release and accompanying financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Wednesday, February 19, 2025, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10195053/fe1bf33c4f. A recording of the webcast will be posted on the Investor Relations section of the...

FRISCO, TX, Feb. 18, 2025 (GLOBE NEWSWIRE) — Comstock Resources, Inc. (“Comstock” or the “Company”) (NYSE: CRK) today reported financial and operating results for the quarter and year ended December 31, 2024. Highlights of 2024‘s Fourth QuarterNatural gas and oil sales, including realized hedging gains, were $336 million. Operating cash flow was $223 million or $0.76 per share. Adjusted EBITDAX for the quarter was $252 million. Adjusted net income was $46.3 million or $0.16 per share for the quarter. Six successful wells were turned to sales in the Western Haynesville with an average daily initial production rate of 40 MMcf per well. Added over 64,000 net acres in the Western Haynesville, increasing total acreage in the play to 518,000 net acres.Financial Results for the Three Months Ended December 31,...

Fiscal 2025 Third Quarter Highlights:Consolidated delivered sales of $522 millionUp 4% versus prior yearOperating margin on a GAAP and Non-GAAP basis improved 20 basis points versus prior year GAAP and Non-GAAP(1) diluted EPS of $0.68 Delivered sales and Non-GAAP(1) operating margin at high end of guidance range Retail segment sales increased 11%Fueled by same-store sales growth and independent La-Z-Boy Furniture Galleries® acquisitions, along with new stores Retail added three newly opened stores, and two newly acquired independent La-Z-Boy Furniture Galleries® stores, with one closure; and announced an additional two-store acquisition expected to close in the fourth quarterMONROE, Mich., Feb. 18, 2025 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB), a global leader in the retail and manufacture of residential...

ATHENS, Greece, Feb. 18, 2025 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK), a global shipping company focusing on the transportation of dry bulk cargoes, today announced its unaudited financial and operating results for the fourth quarter of 2024 and the year ended December 31, 2024. Unless otherwise indicated or unless the context requires otherwise, all references in this press release to “we,” “us,” “our,” or similar references, mean Star Bulk Carriers Corp. and, where applicable, its consolidated subsidiaries. Financial Highlights(Expressed in thousands of U.S. dollars, except for daily rates and per share data) Fourth quarter2024 Fourth quarter2023 Twelve months ended December 31, 2024 Twelve months ended December 31,...

HAMILTON, Bermuda, Feb. 18, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT) today announced results for its fourth quarter ended December 31, 2024Combined ratio of 90.2% in the fourth quarter for Core business, representing a 3.2 point improvement versus prior year, resulting in a full year 2024 Core combined ratio of 91.0% and Core underwriting income of $200 million Growth in the quarter of 21% on gross premiums written for continuing lines business (excluding 2023 exited programs), contributing to 10% growth for the full year Fourth quarter net loss of $21 million, materially impacted by three significant items linked to our efforts to reposition the Company, including the CM Bermuda repurchase transaction, closure of previously announced LPT transaction with Enstar, and the write-down...

CAMPBELL, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced financial results for the fourth quarter and year ended December 31, 2024 and provided first quarter and full year 2025 guidance. “In the fourth quarter of 2024, we achieved a record Annual Contract Value plus royalties of $65.1 million, driven by strong demand for our commercial semiconductor System IP products, particularly in AI-driven enterprise computing and automotive SoCs,” said K. Charles Janac, President and CEO of Arteris. “As AI adoption accelerates across data centers, autonomous driving, and edge devices, the growing complexity of both high performance and traditional technologies like MCUs is fueling demand for the efficiency enabled by Arteris’...

OKLAHOMA CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today reported financial and operational results for the fourth-quarter 2024. The company also declared its quarterly dividend and provided a 2025 outlook. Devon’s earnings release, supplemental financial tables, guidance and related earnings presentation can be accessed via the Investor Relations section of Devon’s website, www.devonenergy.com. The company’s fourth-quarter conference call will be held at 10:00 a.m. Central time (11:00 a.m. Eastern time) on Wednesday, Feb. 19, 2025, and will serve primarily as a forum for analyst and investor questions and answers. ABOUT DEVON ENERGY Devon Energy is a leading oil and gas producer in the U.S. with a diversified multi-basin portfolio headlined by a world-class acreage position in the Delaware Basin. Devon’s...

MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Summary & Recent Business Highlights:Total revenue increased 10% year-over-year to $85.6 million Gross margin of 75% versus 72% in Q4 2023 Net income of $9.7 million versus $8.2 million in Q4 2023 Adjusted EBITDA of $16.2 million versus $15.4 million in Q4 2023 Expanded launch of Nimbl to include patients with lower extremity lymphedema Appointed Laura King to Board of Directors Promoted Aaron Snodgrass to Senior Vice President, Sales, effective February 18, 2025Full Year 2024 Summary:Total revenue...

SAN FRANCISCO, Feb. 18, 2025 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its second quarter fiscal year 2025 ended February 1, 2025 after market close on Tuesday, March 11, 2025. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of the call will be accessible on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com. To access the call by phone, please register at this registration link. Upon registration, telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the...

Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in patients with mCRPC Entered into clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC-114 in combination with subcutaneous amivantamab for the first-line treatment of NSCLC patients with EGFR exon 20 insertion mutations Expects to report seven data readouts across ORIC-114 and ORIC-944 clinical programs over the next 18 months, with potential initiation of registrational trials in 2H25 and early 2026 Cash and investments of $256 million expected to fund operating plan into late 2026 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused...